当前位置:药药网 / 药品研发 / 美国药品上市后承诺数据库
EVARREST, Fibrin Sealant Patch
药品名称
EVARREST, Fibrin Sealant Patch
承诺描述
Deferred pediatric study under PREA for use with manual compression as an adjunct to hemostasis in pediatric patients aged 1 month to less than 18 years undergoing surgery, when control of bleeding by conventional surgical techniques (such as suture, ligature, and cautery) is ineffective or impractical.
承诺状态描述
Study is ongoing. .